CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients who stopped responding to standard treatments
Disease control Recruiting nowThis study tests a new drug called ELVN-001 for people with chronic myeloid leukemia (CML) whose cancer has stopped responding to or who cannot tolerate current treatments. About 250 adults with CML will receive the drug to find the safest dose and check for side effects. The goa…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New vaccine aims to shield stem cell patients from deadly virus
Prevention Recruiting nowThis early-stage trial tests a vaccine (CMV-MVA Triplex) given to both stem cell donors and recipients to boost immunity against cytomegalovirus (CMV), a common and dangerous infection after transplant. About 46 people with various blood cancers or disorders will take part. The g…
Matched conditions: CHRONIC PHASE CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated May 14, 2026 12:06 UTC